Diabetes Mellitus, Type 2: all 9,590 studies
Page 76 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 DiabetesCompletedNCT01607294Phase 2
- Biomarkers of Diabetic Retinopathy ProgressionCompletedNCT01607190
- The Effect of CBT- Based Weight Loss Program on ObesityCompletedNCT01606904Not applicable
- A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 DiabetesCompletedNCT01606397Phase 1
- A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 DiabetesCompletedNCT01606371Phase 1
- Effect of Repaglinide on Postprandial Lipemia in Type 2 DiabetesCompletedNCT01605773Phase 4
- Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery DiseaseCompletedNCT01604213Phase 4
- Type II Diabetes Mellitus in Patients Exposed to Pravastatin and ParoxetineCompletedNCT01602913
- Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 DiabetesCompletedNCT01602003Phase 3
- Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 DiabetesCompletedNCT01601990Phase 3
- Weight Loss Study for People With Type 2 DiabetesCompletedNCT01601574Phase 3
- Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic PatientsCompletedNCT01600690Phase 4
- Register for Patients With Diabetic Foot Syndrome and Critical Limb IschemiaTerminatedNCT01599442
- Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic PatientsCompletedNCT01599338Not applicable
- A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy SubjectsCompletedNCT01597713Phase 1
- Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric BandingTerminatedNCT01597531Phase 4
- Lifestyle Therapy for Youth With Type 2 DiabetesCompletedNCT01597154Not applicable
- Jordan Diabetes Microclinic ProjectCompletedNCT01596244Not applicable
- The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 DiabetesCompletedNCT01595789Phase 4
- Comparison Between aPDT and Systemic Doxycycline on Non-surgical Periodontal Therapy in Type 2 DiabeticsCompletedNCT01595594Phase 3
- The Clinical and Economic Impacts of e-Heath on DiabetesCompletedNCT01595269Not applicable
- Testing the Effect of the InsuPad Device in Daily Life ConditionsCompletedNCT01594801Not applicable
- Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical WardsCompletedNCT01594060Phase 4
- Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes PatientsCompletedNCT01593371Not applicable
- A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 DiabetesWithdrawnNCT01593137Phase 4
- Diabetes Mellitus Community Based Screening in Minority PopulationsStatus unknownNCT01591525
- Renal Denervation in Diabetic NephropathyCompletedNCT01588795Phase 4
- Effects of Short-term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes PatientsStatus unknownNCT01588743Not applicable
- To Evaluate Clinical Outcome and Injection Compliance of ScilinCompletedNCT01588639
- DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic PatientsStatus unknownNCT01588587
- Metabolic Effects of a Pre-meal Protein Drink With or Without Added Amino Acids at a Subsequent Composite MealCompletedNCT01586780Not applicable
- Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 DiabetesCompletedNCT01586442Phase 3
- Dietary Intervention in Diabetes Mellitus (DIDM)- Intermediate and Acute EffectsStatus unknownNCT01585818Phase 2
- Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin AnaloguesCompletedNCT01585506
- Effect of Vitamin D Supplementation on Blood Pressure and HbA1c Levels in Patients With T2DCompletedNCT01585051Phase 3
- Small Dense Low-density Lipoprotein in Patients With Prediabetes and Type 2 DiabetesStatus unknownNCT01584856
- Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes MellitusCompletedNCT01582230Phase 3
- Molecular Regulation of Muscle Glucose MetabolismTerminatedNCT01581736Phase 1
- The Effects of Immersion in Dead Sea Water on Glucose Levels in Type 2 Diabetes Mellitus PatientsCompletedNCT01580852Not applicable
- Training, Detraining, Retraining and Glycemic Control in Patients With Type 2 DiabetesCompletedNCT01580475Not applicable
- The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic SubjectsCompletedNCT01579981Not applicable
- Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 DiabetesCompletedNCT01578837Phase 1/2
- Healthy Moms, Healthy BabiesCompletedNCT01578460Not applicable
- Stress Management Among Latinos With Type 2 DiabetesCompletedNCT01578096Not applicable
- Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined TherapyCompletedNCT01577095Phase 2
- A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal DialysisWithdrawnNCT01576887Phase 2
- Safety Study of Mesenchymal Precursor Cells in Type 2 DiabetesCompletedNCT01576328Phase 1/2
- Korean Post-marketing Surveillance for Onglyza®CompletedNCT01575483
- A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes MellitusTerminatedNCT01574365Phase 2
- Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male SubjectsCompletedNCT01572753Phase 1
- Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 DiabetesCompletedNCT01572649Phase 1
- A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes MellitusTerminatedNCT01572610Phase 2
- Evaluation of SCOUT DS Device in the Diagnosis of Diabetes MellitusCompletedNCT01572415
- Postprandial Insulin Secretion, Oxidative Stress and Gastrointestinal Peptides in Patients With Type 2 Diabetes Versus Healthy SubjectsCompletedNCT01572402Not applicable
- A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes MellitusCompletedNCT01571661Phase 1
- Whey Protein on Posprandial Glucose, Insulin GLP-1, GIP and DPP4 in Type 2 DiabetesCompletedNCT01571622Not applicable
- Use of Mobile Technology to Promote Sustained Lifestyle Changes to Prevent Type 2 Diabetes in India and the UKCompletedNCT01570946Not applicable
- Phielix et al.: Hepatic Fat Content and AdipokinesCompletedNCT01570660Not applicable
- Large Scale Demonstrator, Webportal DiabetesCompletedNCT01570140
- Life-Long Monitoring of Diabetes Mellitus in Veneto RegionCompletedNCT01569893Not applicable
- Text to Move (TTM)StudyCompletedNCT01569243Phase 2
- Effect of Incretin-related Drugs on Dietary Intake in Japanese Patients With Type 2 Diabetes MellitusStatus unknownNCT01568125
- Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 DiabetesCompletedNCT01565733
- Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin MonotherapyStatus unknownNCT01565096Phase 4
- The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride MetabolismCompletedNCT01564550
- Effects of Purple Vegetables on Cardiovascular Disease (CVD) Risk FactorsStatus unknownNCT01564498Phase 1
- Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 DiabetesCompletedNCT01562561Phase 3
- Reducing Obesity and Type 2 Diabetes in High Risk YouthCompletedNCT01560676Phase 2/3
- Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM)CompletedNCT01560546Phase 4
- Egg Protein Hydrolysate and Vascular FunctionCompletedNCT01559896Not applicable
- Long-term of 10 Years Results of a Prospective Longitudinal StudyStatus unknownNCT01557972
- CDRM Study: Computer-assisted Diabetes Risk Management-for Secondary and Tertiary Prevention of T2DM ComplicationsCompletedNCT01556529Not applicable
- Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal ImpairmentCompletedNCT01555008Phase 1
- A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mgCompletedNCT01554631Phase 1
- Effects of Acute Exercise on Acetylcarnitine Concentration in Endurance Trained and Untrained SubjectsCompletedNCT01553968Not applicable
- Saxagliptin and AtherosclerosisCompletedNCT01552018Phase 4
- Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in FranceCompletedNCT01552005
- Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 DiabetesWithdrawnNCT01551446Phase 1
- Bias Source of Signal in SCOUT DSTerminatedNCT01550328
- Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 DiabetesTerminatedNCT01549769Phase 1
- Efficacy and Safety of Levemir® Used as Basal InsulinCompletedNCT01548248
- Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 TreatmentCompletedNCT01548235
- CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose TargetCompletedNCT01548222
- NOX-E36 in Patients With Type 2 Diabetes Mellitus and AlbuminuriaCompletedNCT01547897Phase 2
- Customer Support Response StudyWithdrawnNCT01547403
- Mobile Sipoo - Telemonitoring With Combined With Active Assistance TechnologyCompletedNCT01547156Not applicable
- Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes MellitusStatus unknownNCT01547104Phase 4
- Mobile Health Technology as an Intervention for Diabetes Self-ManagementStatus unknownNCT01546844Not applicable
- Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With RanolazineCompletedNCT01546597Phase 1
- Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mgCompletedNCT01546558Phase 1
- Observational Study to Evaluate the Safety of Levemir® in Patients With DiabetesCompletedNCT01545791
- A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy VolunteersCompletedNCT01545570Phase 1
- Empowering Primary Care Providers and Patients to Improve Chronic Disease Outcomes: The EMPOWER Participatory Action Research (EMPOWER - PAR)CompletedNCT01545401Early Phase 1
- Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes MellitusStatus unknownNCT01545024
- Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and HyposCompletedNCT01542489
- The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment SatisfactionCompletedNCT01542476
- Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 DiabetesCompletedNCT01542463
- An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes MellitusCompletedNCT01542424
- Liraglutide Use in Prader-Willi SyndromeTerminatedNCT01542242Phase 4
- Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes MellitusCompletedNCT01542060